Author： Doggrell Sheila A
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.6, 2003-06, pp. : 999-1001
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
Access to resources
Recommend
Natalizumab knocks out multiple sclerosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. :
Natalizumab knocks out multiple sclerosis
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :
Natalizumab in multiple sclerosis: proceed with caution?
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. :
Natalizumab benefits QOL in multiple sclerosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 577, 2009-01 ,pp. :